Sep 10, 2013 8:48 AM PDT
A patented drug administration technique is set to revolutionize the industry.
Aug 8, 2013 5:21 AM PDT
Small cap stocks ArthroCare Corporation (ARTC), EDAP TMS S.A. (EDAP), SafeStitch Medical Inc (SFES) and Arch Therapeutics Inc (ARTH) are all somehow involved in laparoscopic surgery or so-called minimally invasive surgery (MIS).
Aug 6, 2013 7:26 AM PDT
Yesterday, Sorrento Therapeutics (SRNE) announced great news from the end-of-phase 2 meeting with the FDA regarding the Cynviloq™ (IG-001; paclitaxel polymeric micelle for Injectable Suspension) development program. Cynviloq is a mid-stage metastatic breast cancer (MBC) and non-small cell lung cancer (NSCLC) drug that was just deemed appropriate for a 525(b)(2) submission.
Jun 6, 2013 8:34 AM PDT
Looking at OPKO’s balance sheet, we can also see some notable improvements after the company’s 3% convertible debt auction earlier in the year. As of March 31st 2013, the company held $182 M in cash, and $238 M in current assets. The biggest liability on the balance sheet at this point is the big pool of convertible notes (valued at $196.4 M), although the interest rate is quite favorable and it must be noted that the debt doesn’t expire until 2033.
Mar 25, 2013 10:08 AM PDT
By Mitchell Clark, B.Comm. for Profit Confidential One of the stock market’s strongest sectors over the last few years has been biotechnology stocks. It’s a very tough group in which to be a speculator, because you cannot predict discoveries or approvals. What...
Mar 8, 2013 8:24 AM PST
While RNA interference has its limits, it’s a very powerful way to attack diseases. There are plenty of indications (many of which are orphan) that can still be targeted through RNA. I also believe that RNA interference is one of the sectors that will be attracting major acquisition or partnership interest from big pharma in the next coming year, which is generally very good for both shareholders and developmental-stage companies.
Feb 21, 2013 8:19 AM PST
Though the CEO of Google Inc. (NASDAQ:GOOG) has been heading for the door, Opko Health Inc. (NYSE:OPK), Murphy Oil Corporation (NYSE:MUR), and Newcastle Investment Corp. (NYSE:NCT) insiders are eating more of their own cooking.
Feb 12, 2013 8:33 AM PST
One of the most controversial features of President Obamas Affordable Care Act (ACA) has been the 2.3% tax on gross sales that medical equipment & appliances will have to pay. The tax became effective at the start of this year despite calls from the industry...
Feb 5, 2013 5:07 AM PST
Opko Health, Inc. (NYSE: OPK) announced the closing of its offering of $175.0 million aggregate principal amount of 3.00% convertible senior notes due 2033 in a private offering. OPKO intends to use the approximately $170.3 million of net proceeds from this...
Jan 29, 2013 10:39 AM PST
Opko Health Inc. (NYSE: OPK) traded in the range of $6.82 and $7.22 during its latest trading session. The stock had opened at $7.06 and is at $6.95, up 5.30 percent from its previous close of $6.60. Opko Health recorded the volume of 7.147 million shares....